Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Janux Therapeutics Stock Is Crushing It This Week

TheMotleyFool

0 0

Why Janux Therapeutics Stock Is Crushing It This Week: https://g.foolcdn.com/editorial/images/772615/big-fish-eating-little-fish.jpg

Janux Therapeutics (NASDAQ: JANX) stock is crushing it. The stock was up 42.4% for the week as of market close on Thursday, according to data from S&P Global Market Intelligence.

The big gain came after Bloomberg reported on Wednesday that Janux was exploring a potential sale. Big drugmakers have expressed interest in acquiring Janux, according to anonymous sources interviewed by Bloomberg.

Janux hasn't publicly commented on the reported acquisition talks. Some investors might think management's silence hints there's truth to the rumors.

Source Fool.com

Like: 0

JANX

Share